Target intelligence / Profile preview

Carnitine shuttle pathway enzymes and transporters

Molecular classification
Enzyme, Transporter
01

Overview

The carnitine shuttle pathway is an essential metabolic system composed of enzymes and transporters that facilitate the import of long-chain fatty acids into the mitochondrial matrix for β-oxidation. The core components include carnitine palmitoyltransferase 1 (CPT1, in the outer mitochondrial membrane), carnitine-acylcarnitine translocase (CACT, encoded by SLC25A20, in the inner mitochondrial membrane), and carnitine palmitoyltransferase 2 (CPT2, in the inner mitochondrial membrane)[1][2][3][6]. Additionally, the plasma membrane transporter OCTN2 (SLC22A5) is responsible for carnitine uptake into cells[3]. Defects in any of these proteins disrupt fatty acid oxidation and energy homeostasis, resulting in metabolic diseases, cardiomyopathy, and muscle weakness. Some pharmacological agents target CPT1 or the carnitine shuttle to manipulate energy metabolism in heart disease or cancer research.

Other names
Carnitine shuttle systemCarnitine transport systemCarnitine palmitoyltransferase system
02

Mechanism of action

Inhibition of carnitine palmitoyltransferase 1 (CPT1) to reduce fatty acid oxidation Supplementation with L-carnitine to restore or enhance fatty acid transport

03

Biological functions

Fatty acid transportEnergy metabolismβ-oxidation of fatty acids
04

Disease associations

Cardiovascular diseaseMetabolic disorders (e.g., primary carnitine deficiency, CPT deficiencies)Neuromuscular disorders
05

Safety considerations

Risk of hypoglycemia and hepatotoxicity with CPT1 inhibitorsAccumulation of toxic fatty acid metabolites in transporter/enzyme deficiencies
06

Interacting drugs

L-carnitine (supplemental therapy)

2 more in the full profile.

07

Biomarkers

Acylcarnitine profiles (measured in blood for diagnosis of fatty acid oxidation disorders)Free and total carnitine levels

Beyond the preview

Go deeper on Carnitine shuttle pathway enzymes and transporters.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carnitine shuttle pathway enzymes and transporters.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call